CR Sanjiu's Yiqi Qingfei Granules Placed on China's Medical Insurance List

MT Newswires Live12-09

China Resources Sanjiu Medical & Pharmaceutical's (SHE:000999) Yiqi Qingfei Granules were included in China's National Reimbursement Drug List for Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance, according to a Hong Kong filing on Monday.

The traditional Chinese medicine is used to strengthen the spleen, the pharmaceutical company said.

The list is effective Jan. 1, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment